Alzheon, Inc. announced that Dennis H. Langer, MD, JD, has been appointed to its Board of Directors. Dr. Langer brings a unique blend of clinical expertise in neuroscience and deep experience in drug development, having served on Boards and in leadership roles in several biotechnology and pharmaceutical companies. Dr. Langer is a Clinical Professor in the Department of Psychiatry at Georgetown University School of Medicine and has extensive experience in biotechnology, pharmaceutical and specialty pharmaceutical companies, having served on Boards and in various leadership and operating roles.

Currently, Dr. Langer serves as a Director of Myriad Genetics, Inc.; Dicerna Pharmaceuticals, Inc.; Delcath Systems, Inc.; and several private companies.